Form 8-K - Current report:
SEC Accession No. 0001104659-21-098596
Filing Date
2021-08-02
Accepted
2021-08-02 09:03:55
Documents
13
Period of Report
2021-07-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118507d9_8k.htm   iXBRL 8-K 37810
  Complete submission text file 0001104659-21-098596.txt   260770

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elan-20210730.xsd EX-101.SCH 3900
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20210730_def.xml EX-101.DEF 27029
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20210730_lab.xml EX-101.LAB 37943
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20210730_pre.xml EX-101.PRE 25641
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2118507d9_8k_htm.xml XML 5162
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 211134892
SIC: 2834 Pharmaceutical Preparations